Office Locations:

303 Wyman Street, Suite 300
Waltham, MA 02451
Phone: 781-472-2743
Fax: 781-472-2642

Get all office locations for this firm with a National Database subscription.


  • Early
  • Early
  • Expansion
  • Growth



  • Food & Agriculture
  • Life Sciences & Healthcare
  • Life Sciences & Healthcare
  • Medical Device



    LSP is one of the world's largest specialized healthcare and biotechnology investment firms. With a history dating back to the late eighties, LSP has grown into a global firm with offices in Amsterdam, Munich and Boston. LSP's investment strategy allows for investments in start-up companies in need of first round venture funding, but also in companies seeking later-stage funding, such as for product development or commercial rollouts. LSP's main areas of focus include drug discovery and development, medical devices, diagnostics, industrial biotech, food & agriculture, and bio materials. Target investee companies typically fall within the EURO 50 million to EURO 1 billion market cap range. LSP's investor base originates from the Benelux, Germany, Switzerland, the UK, the Nordic countries and the U.S. Total funds raised to date are at approximately EURO 650 million. Investments per company typically range in size from EURO 1 million up to EURO 15 million over the life of an investment. The firm launched its Euronext-listed LSP Life Sciences Fund in April 2011, with the aim to provide investors with access to the high tech and high growth sector of publicly-traded life sciences companies. In 2017, LSP launched LSP HEF 2 with a fund volume of EUR 280 million targeting investment opportunities in private medical technology companies which offer products that can both improve the quality of patient care and lower healthcare spending.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Anne Portwich PhD Partner
    Clemens van Blitterswijk PhD Partner
    Felice Verduyn-van Weegen Investment Manager
    Fouad Azzam General Partner
    Geraldine O'Keeffe Partner


    Recent Funding Events (trailing 12 months):







      HotSpot Therapeutics



      Series C


    Portfolio companies include:

      HotSpot Therapeutics
        web link

        web link


    Recent News: